Xcout Intelabrdn Life Sciences Investors Shares of competitors & alternatives
The 12 closest competitors and alternatives to abrdn Life Sciences Investors Shares of among asset management companies — ranked by similarity to what abrdn Life Sciences Investors Shares of actually does, not by market-cap band.
Subscribe to see abrdn Life Sciences Investors Shares of’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About abrdn Life Sciences Investors Shares of
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a diverse range of industries such as biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, and medical devices and supplies. The fund also extends its investment purview to include the agriculture and environmental management sectors. It predominantly allocates capital to growth-oriented businesses, particularly those with small market capitalizations. Investment decisions are rooted in rigorous fundamental analysis, which assesses critical factors like a company's market position for its offerings, the acumen of its management team, its technological prowess, and its capability to either self-finance expansion or attract external funding to build its portfolio. The fund's performance is gauged against two key benchmarks: the NASDAQ Biotech Index and the S&P 500 Index.
abrdn Life Sciences Investors Shares of at a glance
abrdn Life Sciences Investors Shares of is an asset management company headquartered in Philadelphia, United States. It is publicly listed (HQL) with a market capitalisation of $649.8M. Xcout tracks 10 named people at abrdn Life Sciences Investors Shares of, including Daniel R. Omstead (Principal Executive Officer, President and Trustee).
abrdn Life Sciences Investors Shares of leadership
- Daniel R. OmsteadPrincipal Executive Officer, President and Trustee
- Peter BrannerChief Investment Officer
- Bill MaherDirector
- Chris LaVictoire MahaiDirector
- Christian PittardDirector
- Kathleen GoetzDirector
4 more named people on record for abrdn Life Sciences Investors Shares of, with roles, board committees and tenure — see the full roster →
Top 12 abrdn Life Sciences Investors Shares of competitors
Ranked by semantic similarity — how close each company is to abrdn Life Sciences Investors Shares of by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar asset management company
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Similar asset management company
The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.
Similar asset management company
BMO Global Smaller Companies PLC operates as a closed-ended equity investment trust, with F&C Investment Business Ltd responsible for its management. The trust's core objective is to invest in publicly traded small-capitalization companies across various global sectors. Its strategy involves identifying both growth-oriented and value opportunities within the small-cap market. Portfolio construction is guided by rigorous fundamental analysis, examining factors such as the caliber of management, competitive position within target markets, future growth blueprints, and the robustness of cash flow generation. To evaluate its performance, the fund employs a composite benchmark consisting of 30% Numis UK Smaller Companies (excluding investment companies) Index and 70% MSCI All Country World ex UK Small Cap Index. Originally founded on February 15, 1889, under the name F&C Smaller Companies plc, the entity is domiciled in the United Kingdom.
Similar asset management company
The Tri-Continental Corporation operates as a closed-end equity mutual fund, managed by Columbia Management Investment Advisers, LLC. Its core strategy involves investing in publicly traded large-capitalization companies spanning various sectors within the United States equity markets. The fund's investment performance is benchmarked against the S&P 500 Index. Established in January 1929, it is legally domiciled in the United States.
Similar asset management company
Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.
Similar asset management company
Managed by Polar Capital LLP, Polar Capital Technology Trust plc operates as a closed-end investment company. Its objective is to allocate capital to publicly listed companies across the globe. The trust primarily focuses on enterprises within the technology sector, alongside those in related, technology-dependent fields such as information, media, communications, environmental solutions, computing, healthcare, and renewable energy. Investments are made across the full spectrum of market capitalizations. Its portfolio is constructed through fundamental analysis, with particular emphasis on management quality, the global spread of key technological trends, and identifying international valuation irregularities. The performance of its portfolio is benchmarked against the Dow Jones World Technology Index (Total Return). Initially known as Henderson Technology Trust Plc, the trust was established in the United Kingdom on December 16, 1996.
Similar asset management company
The Tortoise Energy Infrastructure Corporation, a closed-end equity mutual fund, is managed by Tortoise Capital Advisors L.L.C. This U.S.-domiciled fund, established on October 29, 2003, invests in publicly traded companies within the United States. Its core strategy involves allocating capital to the energy infrastructure sector, specifically targeting businesses engaged in the transportation, processing, storage, distribution, or marketing of natural gas, natural gas liquids (such as propane), coal, crude oil, or refined petroleum products. It also seeks out firms involved in the exploration, development, management, or production of these commodities. The portfolio's main holdings include publicly traded Master Limited Partnerships (MLPs) and stocks of companies with a market capitalization exceeding $100 million.
Similar asset management company
The Eaton Vance Tax-Managed Buy-Write Opportunities Fund, a closed-end equity mutual fund, is operated by Eaton Vance Management and co-managed by Parametric Portfolio Associates LLC. Its investment strategy focuses on publicly traded U.S. equities, specifically targeting companies across a diverse range of sectors. A key part of its methodology involves writing (selling) call options on one or more major U.S. indices, covering a substantial portion of its common stock portfolio's value. The fund measures its performance against a suite of benchmarks: the S&P 500 Index, the CBOE S&P 500 BuyWrite Index, the NASDAQ-100 Index, and the CBOE NASDAQ-100 BuyWrite Index. This U.S.-domiciled fund was established on June 30, 2005.
Similar asset management company
The Bankers Investment Trust PLC operates as a closed-ended investment company, managed by Henderson Investment Funds Limited, with co-management responsibilities held by Henderson Global Investors Limited. This trust strategically invests in publicly listed equities across international markets, seeking to diversify its holdings across various industry sectors. Its core investment approach targets dividend-paying value stocks, primarily within the large and mid-capitalization segments. Portfolio construction is driven by a meticulous bottom-up stock selection process, underpinned by rigorous fundamental analysis. The trust measures its performance against the FTSE All-Share Index. Founded in April 1888, The Bankers Investment Trust PLC is domiciled in the United Kingdom.
Similar asset management company
StoneCastle Financial Corp., a closed-end mutual fund managed by StoneCastle Asset Management LLC, implements a diversified investment approach. Its equity holdings are primarily concentrated in publicly traded companies within the U.S. banking industry, specifically including dividend-paying growth and value stocks. As for its fixed-income allocation, the fund invests in subordinated debt securities that maintain a Kroll Ratings assessment of BBB- or higher. The fund builds its portfolio through a meticulous bottom-up, fundamental analysis strategy. This process involves a comprehensive review of past and future financial data, direct interviews with the management and essential personnel of potential banking investments, and the development of detailed financial models and projections. Furthermore, the fund carefully monitors broader economic indicators, such as changes in interest rates, unemployment rates, home prices, and overall economic activity. Proprietary research also plays a crucial role in shaping its investment choices. StoneCastle Financial Corp. was established on February 7, 2013, and is domiciled in the United States.
Similar asset management company
Managed by Quadravest Capital Management Inc., TDb Split Corp. operates as a Canadian-domiciled, closed-end equity mutual fund established on May 24, 2007. The fund's investment strategy focuses on public equity markets within Canada, specifically targeting companies within the banking sector. A significant portion of its capital is allocated to the common shares of Toronto-Dominion Bank. Its financial performance is measured against the S&P TSX Financial Index.
Similar asset management company
Managed by Quadravest Capital Management Inc., Canadian Life Companies Split Corp. functions as a closed-ended equity mutual fund dedicated to investing in the public equity markets of Canada. Its strategy primarily involves targeting companies within the life insurance sector, with a significant allocation towards four major publicly traded firms: Great-West Lifeco Inc., Industrial Alliance Insurance and Financial Services Inc., Manulife Financial Corporation, and Sun Life Financial Inc. To assemble its portfolio, the fund employs a rigorous fundamental analysis methodology, examining factors such as a company's earnings history, its price-to-earnings multiple in comparison to peers, cash flow, dividend payouts, market standing, and potential for future expansion. The performance of its holdings is benchmarked against the S&P TSX Financial Index. This Canadian-based corporation was founded on April 18, 2005.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of abrdn Life Sciences Investors Shares of and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for abrdn Life Sciences Investors Shares ofand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →